Buck D J, Richmond R L, Mendelsohn C P
Department of Dental Public Health & Oral Health Services Research, King's College, London, United Kingdom.
Prev Med. 2000 Dec;31(6):641-8. doi: 10.1006/pmed.2000.0756.
The objectives were to present a cost-effectiveness analysis of a smoking cessation program delivered by physicians and compare results to other smoking cessation interventions.
Retrospective effectiveness figures from a previous evaluation of the smoking cessation program were supplemented with estimates based on researched assumptions. Net abstinence rates were determined for smokers, depending on their stage of readiness to quit, that is, "prepared," "contemplative," and "precontemplative," leading to an assessment of the number of smokers achieving abstinence as a result of the Smokescreen intervention. Costs were calculated from the perspectives of smokers, family physicians, organizers, trainers, and all parties combined. Assumptions were varied with a sensitivity analysis.
Baseline costs per additional abstainer were $183 based on physicians' intervention costs at 1995 prices. This is the figure most comparable to previously conducted economic evaluations of smoking cessation interventions. Sensitivity analysis varying the perspective and under optimistic and pessimistic assumptions about effectiveness produced a wide variety of estimates. The decision to include or exclude training costs had a particularly important bearing on the estimates. However, under reasonable assumptions the cost per additional quitter compares favorably to smoking and other medical and health care interventions worldwide.
The program appears cost-effective when compared to other smoking cessation and health promotion interventions and illustrates the potential for retrospective cost-effectiveness analysis of interventions.
本研究旨在对医生实施的戒烟项目进行成本效益分析,并将结果与其他戒烟干预措施进行比较。
通过基于研究假设的估计值,对先前戒烟项目评估中的回顾性有效性数据进行补充。根据吸烟者准备戒烟的阶段,即“准备戒烟”“考虑戒烟”和“未考虑戒烟”,确定吸烟者的净戒烟率,从而评估因“烟幕”干预措施而实现戒烟的吸烟者人数。从吸烟者、家庭医生、组织者、培训师以及所有相关方的角度计算成本。通过敏感性分析对假设进行了调整。
以1995年价格计算,基于医生干预成本得出的每增加一名戒烟者所需的基线成本为183美元。这一数字与先前进行的戒烟干预措施经济评估最为可比。敏感性分析通过改变视角以及在对有效性的乐观和悲观假设下进行分析,得出了各种各样的估计值。是否纳入培训成本的决定对估计值有着特别重要的影响。然而,在合理假设下,每增加一名戒烟者的成本与全球范围内的吸烟及其他医疗保健干预措施相比具有优势。
与其他戒烟和健康促进干预措施相比,该项目似乎具有成本效益,并说明了对干预措施进行回顾性成本效益分析的潜力。